Friday, May 28, 2021
NCCN, the National Comprehensive Cancer Network, establishes and publishes guidelines to treating different cancers. In this video, OncLive specialists discuss the latest treatment guidelines. If you would like to download a pdf version of what the latest guidelines are, you can do so by following this link.
Friday, May 21, 2021
Targeting Progesterone Signaling Prevents Metastatic Ovarian Cancer" was released in the journal PNAS.
This study is important to women who have the BRCA-1 mutation. Women with this mutation generally produce high levels of progesterone during their menstrual cycles. Targeting these women with an anti-progesterone medication may provide these high risk women with an alternative to prophylactic breast or ovarian surgery.
To find out more about this study, follow this link.
Tuesday, May 18, 2021
This is a wonderful in-depth look at the treatment options for OC and how it is evolving.
Tuesday, May 11, 2021
Friday, May 7, 2021
BVX-0918A, the vaccine, uses the patient's own cancer cells to make them more recognizable to the body's defense system. Specifically, the vaccine would make the cancer cell more visible for cancer-killing T-cells. BioVaxys is also planning to combine their vaccine with checkpoint inhibitors, another class of cancer medication, that block certain proteins from shutting down the body's immune response. Cancer cells hijack this natural function in the body and therefore hide from the immune system.
To read more about this fascinating research, follow this link.